{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T17:17:47Z","timestamp":1793639867693,"version":"4.5.1"},"reference-count":197,"publisher":"Bentham Science Publishers Ltd.","issue":"18","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CMC"],"published-print":{"date-parts":[[2022,6]]},"abstract":"<jats:sec>\n                    <jats:title>:<\/jats:title>\n                    <jats:p>In this review, we discussed the biological targets of carnitine, its effects on\nimmune function, and how L-carnitine supplementation may help critically ill patients.\nL-carnitine is a potent antioxidant. L-carnitine depletion has been observed in prolonged\nintensive care unit (ICU) stays, while L-carnitine supplementation has beneficial effects\nin health promotion and regulation of immunity. It is essential for the uptake of fatty\nacids into mitochondria. By inhibiting the ubiquitin-proteasome system, down-regulating\nthe apelin receptor in cardiac tissue, and reducing \u03b2-oxidation of fatty acid, carnitine may\ndecrease vasopressor requirement in septic shock and improve clinical outcomes of this\ngroup of patients. We also reviewed animal and clinical studies that have been recruited\nfor evaluating the beneficial effects of L-carnitine in the management of sepsis\/ septic\nshock. Additional clinical data are required to evaluate the optimal daily dose and duration\nof L-carnitine supplementation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2174\/0929867328666211117092345","type":"journal-article","created":{"date-parts":[[2021,11,17]],"date-time":"2021-11-17T23:21:32Z","timestamp":1637191292000},"page":"3300-3323","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["L-carnitine: Searching for New Therapeutic Strategy for Sepsis Management"],"prefix":"10.2174","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9361-1641","authenticated-orcid":true,"given":"Adeleh","family":"Sahebnasagh","sequence":"first","affiliation":[{"name":"Clinical Research Center, Department of Internal Medicine, School of Medicine, North Khorasan University\nof Medical Sciences, Bojnurd, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Razieh","family":"Avan","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy, Medical Toxicology and Drug\nAbuse Research Center (MTDRC), School of Pharmacy, Birjand University of Medical Sciences, Birjand,\nIran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahila","family":"Monajati","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Golestan University of Medical Sciences, Gorgan, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javad","family":"Hashemi","sequence":"additional","affiliation":[{"name":"Department\nof Pathobiology and Laboratory Sciences, School of Medicine, North Khorasan University of Medical\nSciences, Bojnurd, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Solomon","family":"Habtemariam","sequence":"additional","affiliation":[{"name":"Pharmacognosy Research Laboratories and Herbal Analysis Services, School of\nScience, University of Greenwich, Central Avenue, Chatham-Maritime, Kent ME4 4TB, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sina","family":"Negintaji","sequence":"additional","affiliation":[{"name":"Student Research Committee, School of Pharmacy, Shahid Sadoughi University of Medical Sciences, Yazd,\nIran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4185-1341","authenticated-orcid":true,"given":"Fatemeh","family":"Saghafi","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy, Faculty of Pharmacy and Pharmaceutical Sciences Research Center,\nShahid Sadoughi University of Medical Sciences, Yazd, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1007\/s00134-017-4683-6","volume":"43","author":"Rhodes A.","year":"2017","unstructured":"Rhodes A.; Evans L.E.; Alhazzani W.; Levy M.M.; Antonelli M.; Ferrer R.; Kumar A.; Sevransky J.E.; Sprung C.L.; Nunnally M.E.; Rochwerg B.; Rubenfeld G.D.; Angus D.C.; Annane D.; Beale R.J.; Bellinghan G.J.; Bernard G.R.; Chiche J.D.; Coopersmith C.; De Backer D.P.; French C.J.; Fujishima S.; Gerlach H.; Hidalgo J.L.; Hollenberg S.M.; Jones A.E.; Karnad D.R.; Kleinpell R.M.; Koh Y.; Lisboa T.C.; Machado F.R.; Marini J.J.; Marshall J.C.; Mazuski J.E.; McIntyre L.A.; McLean A.S.; Mehta S.; Moreno R.P.; Myburgh J.; Navalesi P.; Nishida O.; Osborn T.M.; Perner A.; Plunkett C.M.; Ranieri M.; Schorr C.A.; Seckel M.A.; Seymour C.W.; Shieh L.; Shukri K.A.; Simpson S.Q.; Singer M.; Thompson B.T.; Townsend S.R.; Van der Poll T.; Vincent J.L.; Wiersinga W.J.; Zimmerman J.L.; Dellinger R.P.; Surviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2016. Intensive Care Med 2017,43(3),304-377","journal-title":"Intensive Care Med"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"e14517","DOI":"10.1111\/ijcp.14517","volume":"75","author":"Oh T.K.","year":"2021","unstructured":"Oh T.K.; Park H.Y.; Han J.Y.; Song I.A.; Prior benzodiazepine use and mortality among adult patients with sepsis: a retrospective population-based cohort study in South Korea. Int J Clin Pract 2021,75(10),e14517","journal-title":"Int J Clin Pract"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/S0140-6736(19)32989-7","volume":"395","author":"Rudd K.E.","year":"2020","unstructured":"Rudd K.E.; Johnson S.C.; Agesa K.M.; Shackelford K.A.; Tsoi D.; Kievlan D.R.; Colombara D.V.; Ikuta K.S.; Kissoon N.; Finfer S.; Fleischmann-Struzek C.; Machado F.R.; Reinhart K.K.; Rowan K.; Seymour C.W.; Watson R.S.; West T.E.; Marinho F.; Hay S.I.; Lozano R.; Lopez A.D.; Angus D.C.; Murray C.J.L.; Naghavi M.; Global, regional, and national sepsis incidence and mortality, 1990-2017: analysis for the Global Burden of Disease Study. Lancet 2020,395(10219),200-211","journal-title":"Lancet"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1097\/00003246-200107000-00002","volume":"29","author":"Angus D.C.","year":"2001","unstructured":"Angus D.C.; Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med Soc 2001,29(7),1303-1310","journal-title":"Crit Care Med Soc"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"1674","DOI":"10.1097\/CCM.0b013e318287f850","volume":"41","author":"Lewis R.J.","year":"2013","unstructured":"Lewis R.J.; Viele K.; Broglio K.; Berry S.M.; Jones A.E.; An adaptive, phase II, dose-finding clinical trial design to evaluate L-carnitine in the treatment of septic shock based on efficacy and predictive probability of subsequent phase III success. Crit Care Med 2013,41(7),1674-1678","journal-title":"Crit Care Med"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1097\/SHK.0000000000000997","volume":"49","author":"Puskarich M.A.","year":"2018","unstructured":"Puskarich M.A.; Evans C.R.; Karnovsky A.; Das A.K.; Jones A.E.; Stringer K.A.; Septic shock nonsurvivors have persistently elevated acylcarnitines following carnitine supplementation. Shock 2018,49(4),412-419","journal-title":"Shock"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1002\/bjs.1800760205","volume":"76","author":"Douglas R.G.","year":"1989","unstructured":"Douglas R.G.; Shaw J.H.; Metabolic response to sepsis and trauma. Br J Surg 1989,76(2),115-122","journal-title":"Br J Surg"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"52S","DOI":"10.1016\/S0899-9007(97)00206-2","volume":"13","author":"Biolo G.","year":"1997","unstructured":"Biolo G.; Toigo G.; Ciocchi B.; Situlin R.; Iscra F.; Gullo A.; Guarnieri G.; Metabolic response to injury and sepsis: changes in protein metabolism. Nutrition 1997,13(9)(Suppl.),52S-57S","journal-title":"Nutrition"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.ccm.2016.01.011","volume":"37","author":"Englert J.A.","year":"2016","unstructured":"Englert J.A.; Rogers A.J.; Metabolism, metabolomics, and nutritional support of patients with sepsis. Clin Chest Med 2016,37(2),321-331","journal-title":"Clin Chest Med"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1097\/00003246-199606000-00039","volume":"24","author":"Proulx F.","year":"1996","unstructured":"Proulx F.; Lacroix J.; Farrell C.A.; Lambert M.; Blood lactate and gastric intramucosal pH during severe sepsis. Crit Care Med 1996,24(6),1092","journal-title":"Crit Care Med"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"414","DOI":"10.18433\/J3JS4C","volume":"16","author":"Hatamkhani S.","year":"2013","unstructured":"Hatamkhani S.; Karimzadeh I.; Elyasi S.; Farsaie S.; Khalili H.; Carnitine and sepsis: a review of an old clinical dilemma. J Pharm Pharm Sci 2013,16(3),414-423","journal-title":"J Pharm Pharm Sci"},{"key":"ref=12","first-page":"477","volume":"52","author":"Levy E.","year":"1968","unstructured":"Levy E.; Slusser R.J.; Ruebner B.H.; Hepatic changes produced by a single dose of endotoxin in the mouse. Electron microscopy. Am J Pathol 1968,52(2),477-502","journal-title":"Am J Pathol"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1097\/00075198-200308000-00004","volume":"9","author":"Tr\u00e4ger K.","year":"2003","unstructured":"Tr\u00e4ger K.; DeBacker D.; Radermacher P.; Metabolic alterations in sepsis and vasoactive drug-related metabolic effects. Curr Opin Crit Care 2003,9(4),271-278","journal-title":"Curr Opin Crit Care"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1002\/phar.2448","volume":"40","author":"Jennaro T.S.","year":"2020","unstructured":"Jennaro T.S.; Using L-Carnitine as a Pharmacologic Probe of the Interpatient and Metabolic Variability of Sepsis. Pharmacotherapy: J Human Pharm Drug Ther 2020,40(9),913-923","journal-title":"Pharmacotherapy: J Human Pharm Drug Ther"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"66","DOI":"10.4161\/viru.26907","volume":"5","author":"Singer M.","year":"2014","unstructured":"Singer M.; The role of mitochondrial dysfunction in sepsis-induced multi-organ failure. Virulence 2014,5(1),66-72","journal-title":"Virulence"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1042\/bst0311133","volume":"31","author":"Eaton S.","year":"2003","unstructured":"Eaton S.; Fukumoto K.; Stefanutti G.; Spitz L.; Zammit V.A.; Pierro A.; Myocardial carnitine palmitoyltransferase I as a target for oxidative modification in inflammation and sepsis. Biochem Soc Trans 2003,31(Pt 6),1133-1136","journal-title":"Biochem Soc Trans"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1177\/0148607113495414","volume":"38","author":"Puskarich M.A.","year":"2014","unstructured":"Puskarich M.A.; Kline J.A.; Krabill V.; Claremont H.; Jones A.E.; Preliminary safety and efficacy of L-carnitine infusion for the treatment of vasopressor-dependent septic shock: a randomized control trial. JPEN J Parenter Enteral Nutr 2014,38(6),736-743","journal-title":"JPEN J Parenter Enteral Nutr"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1186\/s13054-018-2275-7","volume":"22","author":"Johansson P.I.","year":"2018","unstructured":"Johansson P.I.; Nakahira K.; Rogers A.J.; McGeachie M.J.; Baron R.M.; Fredenburgh L.E.; Harrington J.; Choi A.M.K.; Christopher K.B.; Plasma mitochondrial DNA and metabolomic alterations in severe critical illness. Crit Care 2018,22(1),360","journal-title":"Crit Care"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/S0140-6736(02)09459-X","volume":"360","author":"Brealey D.","year":"2002","unstructured":"Brealey D.; Brand M.; Hargreaves I.; Heales S.; Land J.; Smolenski R.; Davies N.A.; Cooper C.E.; Singer M.; Association between mitochondrial dysfunction and severity and outcome of septic shock. Lancet 2002,360(9328),219-223","journal-title":"Lancet"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1164\/rccm.201003-0326OC","volume":"182","author":"Carr\u00e9 J.E.","year":"2010","unstructured":"Carr\u00e9 J.E.; Orban J.C.; Re L.; Felsmann K.; Iffert W.; Bauer M.; Suliman H.B.; Piantadosi C.A.; Mayhew T.M.; Breen P.; Stotz M.; Singer M.; Survival in critical illness is associated with early activation of mitochondrial biogenesis. Am J Respir Crit Care Med 2010,182(6),745-751","journal-title":"Am J Respir Crit Care Med"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1007\/BF03261931","volume":"51","author":"Reuter S.E.","year":"2012","unstructured":"Reuter S.E.; Evans A.M.; Carnitine and acylcarnitines: pharmacokinetic, pharmacological and clinical aspects. Clin Pharmacokinet 2012,51(9),553-572","journal-title":"Clin Pharmacokinet"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"2176","DOI":"10.1016\/S0021-9258(19)44202-6","volume":"248","author":"Tanphaichitr V.","year":"1973","unstructured":"Tanphaichitr V.; Broquist H.P.; Role of lysine and -N-trimethyllysine in carnitine biosynthesis. II. Studies in the rat. J Biol Chem 1973,248(6),2176-2181","journal-title":"J Biol Chem"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1196\/annals.1320.012","volume":"1033","author":"Famularo G.","year":"2004","unstructured":"Famularo G.; De Simone C.; Trinchieri V.; Mosca L.; Carnitines and its congeners: a metabolic pathway to the regulation of immune response and inflammation. Ann N Y Acad Sci 2004,1033(1),132-138","journal-title":"Ann N Y Acad Sci"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/1743-7075-7-30","volume":"7","author":"Flanagan J.L.","year":"2010","unstructured":"Flanagan J.L.; Simmons P.A.; Vehige J.; Willcox M.D.; Garrett Q.; Role of carnitine in disease. Nutr Metab (Lond) 2010,7(1),30","journal-title":"Nutr Metab (Lond)"},{"key":"ref=25","first-page":"E31","volume":"256","author":"Takeyama N.","year":"1989","unstructured":"Takeyama N.; Takagi D.; Matsuo N.; Kitazawa Y.; Tanaka T.; Altered hepatic fatty acid metabolism in endotoxicosis: effect of L-carnitine on survival. Am J Physiol 1989,256(1 Pt 1),E31-E38","journal-title":"Am J Physiol"},{"key":"ref=26","first-page":"83","volume":"11","author":"Gasparetto A.","year":"1991","unstructured":"Gasparetto A.; Corbucci G.G.; De Blasi R.A.; Antonelli M.; Bagiella E.; D\u2019Iddio S.; Trevisani C.; Influence of acetyl-L-carnitine infusion on haemodynamic parameters and survival of circulatory-shock patients. Int J Clin Pharmacol Res 1991,11(2),83-92","journal-title":"Int J Clin Pharmacol Res"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1513\/AnnalsATS.201409-415OC","volume":"12","author":"Puskarich M.A.","year":"2015","unstructured":"Puskarich M.A.; Finkel M.A.; Karnovsky A.; Jones A.E.; Trexel J.; Harris B.N.; Stringer K.A.; Pharmacometabolomics of l-carnitine treatment response phenotypes in patients with septic shock. Ann Am Thorac Soc 2015,12(1),46-56","journal-title":"Ann Am Thorac Soc"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/0167-5699(95)80159-6","volume":"16","author":"Famularo G.","year":"1995","unstructured":"Famularo G.; De Simone C.; A new era for carnitine? Immunol Today 1995,16(5),211-213","journal-title":"Immunol Today"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1177\/0148607185009004483","volume":"9","author":"Nanni G.","year":"1985","unstructured":"Nanni G.; Pittiruti M.; Giovannini I.; Boldrini G.; Ronconi P.; Castagneto M.; Plasma carnitine levels and urinary carnitine excretion during sepsis. JPEN J Parenter Enteral Nutr 1985,9(4),483-490","journal-title":"JPEN J Parenter Enteral Nutr"},{"key":"ref=30","doi-asserted-by":"crossref","first-page":"673","DOI":"10.2174\/1871530320666200727150450","volume":"21","author":"Abdollahi H.","year":"2021","unstructured":"Abdollahi H.; The Effect of L-Carnitine on Mortality Rate in Septic Patients: A Systematic Review and Meta-Analysis on Randomized Clinical Trials. Endoc Metab Immune Disorders-Drug Targets (Formerly Current Drug Targets-Immune, Endocrine  2021,21(4),673-681","journal-title":"Endoc Metab Immune Disorders-Drug Targets (Formerly Current Drug Targets-Immune, Endocrine"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1007\/s00134-018-5085-0","volume":"44","author":"Levy M.M.","year":"2018","unstructured":"Levy M.M.; Evans L.E.; Rhodes A.; The surviving sepsis campaign bundle: 2018 update. Intensive Care Med 2018,44(6),925-928","journal-title":"Intensive Care Med"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1001\/jama.2014.2637","volume":"311","author":"Kaukonen K-M.","year":"2014","unstructured":"Kaukonen K-M.; Bailey M.; Suzuki S.; Pilcher D.; Bellomo R.; Mortality related to severe sepsis and septic shock among critically ill patients in Australia and New Zealand, 2000-2012. JAMA 2014,311(13),1308-1316","journal-title":"JAMA"},{"key":"ref=33","doi-asserted-by":"crossref","first-page":"51","DOI":"10.5935\/0103-507X.20150009","volume":"27","author":"Giacomini M.G.","year":"2015","unstructured":"Giacomini M.G.; Lopes M.V.; Gandolfi J.V.; Lobo S.M.; Septic shock: a major cause of hospital death after intensive care unit discharge. Rev Bras Ter Intensiva 2015,27(1),51-56","journal-title":"Rev Bras Ter Intensiva"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1186\/s13063-019-3254-2","volume":"20","author":"Hager D.N.","year":"2019","unstructured":"Hager D.N.; Hooper M.H.; Bernard G.R.; Busse L.W.; Ely E.W.; Fowler A.A.; Gaieski D.F.; Hall A.; Hinson J.S.; Jackson J.C.; Kelen G.D.; Levine M.; Lindsell C.J.; Malone R.E.; McGlothlin A.; Rothman R.E.; Viele K.; Wright D.W.; Sevransky J.E.; Martin G.S.; The Vitamin C, Thiamine and Steroids in Sepsis (VICTAS) Protocol: a prospective, multi-center, double-blind, adaptive sample size, randomized, placebo-controlled, clinical trial. Trials 2019,20(1),197","journal-title":"Trials"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"e5016","DOI":"10.7759\/cureus.5016","volume":"11","author":"Masood H.","year":"2019","unstructured":"Masood H.; Burki A.M.; Sultan A.; Sharif H.; Ghauri A.; Khan S.; Qureshi M.S.S.; Qadeer A.; Rasheed G.; Effect of intravenous vitamin C, thiamine, and hydrocortisone (the metabolic resuscitation protocol) on early weaning from vasopressors in patients with septic shock. A descriptive case series study. Cureus 2019,11(6),e5016","journal-title":"Cureus"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1097\/01.mco.0000247466.41661.ba","volume":"9","author":"Berger M.M.","year":"2006","unstructured":"Berger M.M.; Shenkin A.; Update on clinical micronutrient supplementation studies in the critically ill. Curr Opin Clin Nutr Metab Care 2006,9(6),711-716","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.cger.2017.01.002","volume":"33","author":"Garpestad E.","year":"2017","unstructured":"Garpestad E.; Devlin J.W.; Polypharmacy and delirium in critically ill older adults: recognition and prevention. Clin Geriatr Med 2017,33(2),189-203","journal-title":"Clin Geriatr Med"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"e14733","DOI":"10.1097\/MD.0000000000014733","volume":"98","author":"Li S.","year":"2019","unstructured":"Li S.; Tang T.; Guo P.; Zou Q.; Ao X.; Hu L.; Tan L.; A meta-analysis of randomized controlled trials: Efficacy of selenium treatment for sepsis. Medicine (Baltimore) 2019,98(9),e14733","journal-title":"Medicine (Baltimore)"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"277","DOI":"10.4314\/ahs.v21i1.36","volume":"21","author":"Kong L.","year":"2021","unstructured":"Kong L.; Wu Q.; Liu B.; The impact of selenium administration on severe sepsis or septic shock: a meta-analysis of randomized controlled trials. Afr Health Sci 2021,21(1),277-285","journal-title":"Afr Health Sci"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"e15473","DOI":"10.1097\/MD.0000000000015473","volume":"98","author":"Zhao Y.","year":"2019","unstructured":"Zhao Y.; Yang M.; Mao Z.; Yuan R.; Wang L.; Hu X.; Zhou F.; Kang H.; The clinical outcomes of selenium supplementation on critically ill patients: a meta-analysis of randomized controlled trials. Medicine (Baltimore) 2019,98(20),e15473","journal-title":"Medicine (Baltimore)"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"CD003703","DOI":"10.1002\/14651858.CD003703.pub3","volume":"2015","author":"Allingstrup M.","year":"2015","unstructured":"Allingstrup M.; Afshari A.; Selenium supplementation for critically ill adults. Cochrane Database System Rev 2015,2015(7),CD003703","journal-title":"Cochrane Database System Rev"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1186\/s13054-016-1529-5","volume":"20","author":"Manzanares W.","year":"2016","unstructured":"Manzanares W.; Lemieux M.; Elke G.; Langlois P.L.; Bloos F.; Heyland D.K.; High-dose intravenous selenium does not improve clinical outcomes in the critically ill: A systematic review and meta-analysis. Crit Care 2016,20(1),356","journal-title":"Crit Care"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s13613-017-0282-5","volume":"7","author":"Lu C.","year":"2017","unstructured":"Lu C.; Sharma S.; McIntyre L.; Rhodes A.; Evans L.; Almenawer S.; Leduc L.; Angus D.C.; Alhazzani W.; Omega-3 supplementation in patients with sepsis: a systematic review and meta-analysis of randomized trials. Ann Intensive Care 2017,7(1),58","journal-title":"Ann Intensive Care"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1186\/s13054-020-03356-w","volume":"24","author":"Pradelli L.","year":"2020","unstructured":"Pradelli L.; Klek S.; Mayer K.; Omar Alsaleh A.J.; Rosenthal M.D.; Heller A.R.; Muscaritoli M.; Omega-3 fatty acid-containing parenteral nutrition in ICU patients: systematic review with meta-analysis and cost-effectiveness analysis. Crit Care 2020,24(1),634","journal-title":"Crit Care"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s12937-018-0356-8","volume":"17","author":"Chen H.","year":"2018","unstructured":"Chen H.; Wang S.; Zhao Y.; Luo Y.; Tong H.; Su L.; Correlation analysis of omega-3 fatty acids and mortality of sepsis and sepsis-induced ARDS in adults: data from previous randomized controlled trials. Nutr J 2018,17(1),57","journal-title":"Nutr J"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"S54","DOI":"10.21037\/jtd.2019.12.85","volume":"12","author":"Colunga Biancatelli R.M.L.","year":"2020","unstructured":"Colunga Biancatelli R.M.L.; Berrill M.; Mohammed Y.H.; Marik P.E.; Melatonin for the treatment of sepsis: the scientific rationale. J Thorac Dis 2020,12(Suppl. 1),S54-S65","journal-title":"J Thorac Dis"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1080\/14767058.2017.1402001","volume":"32","author":"Tang Z.","year":"2019","unstructured":"Tang Z.; Wei Z.; Wen F.; Wu Y.; Efficacy of zinc supplementation for neonatal sepsis: a systematic review and meta-analysis. J Matern Fetal Neonatal Med 2019,32(7),1213-1218","journal-title":"J Matern Fetal Neonatal Med"},{"key":"ref=48","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s00394-021-02604-1","volume":"61","author":"Rouhani P.","year":"2022","unstructured":"Rouhani P.; Rezaei Kelishadi M.; Saneei P.; Effect of zinc supplementation on mortality in under 5-year children: a systematic review and meta-analysis of randomized clinical trials. Eur J Nutr 2022,61(1),37-54","journal-title":"Eur J Nutr"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.clnesp.2018.10.011","volume":"29","author":"Cherukuri L.","year":"2019","unstructured":"Cherukuri L.; Gewirtz G.; Osea K.; Tayek J.A.; Vitamin A treatment for severe sepsis in humans; a prospective randomized double blind placebo-controlled clinical trial. Clin Nutr ESPEN 2019,29,49-51","journal-title":"Clin Nutr ESPEN"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1179\/2046905515Y.0000000042","volume":"36","author":"Ponnarmeni S.","year":"2016","unstructured":"Ponnarmeni S.; Kumar Angurana S.; Singhi S.; Bansal A.; Dayal D.; Kaur R.; Patial A.; Verma Attri S.; Vitamin D deficiency in critically ill children with sepsis. Paediatr Int Child Health 2016,36(1),15-21","journal-title":"Paediatr Int Child Health"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1097\/ALN.0000000000001882","volume":"127","author":"Keane C.","year":"2017","unstructured":"Keane C.; Jerkic M.; Laffey J.G.; Stem cell\u2013based therapies for sepsis. Anesthesiology 2017,127(6),1017-1034","journal-title":"Anesthesiology"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1186\/s13054-019-2548-9","volume":"23","author":"Zhang X.","year":"2019","unstructured":"Zhang X.; Yang K.; Chen L.; Liao X.; Deng L.; Chen S.; Ji Y.; Vitamin A deficiency in critically ill children with sepsis. Crit Care 2019,23(1),267","journal-title":"Crit Care"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1016\/j.clnu.2017.05.006","volume":"37","author":"Langlois P.L.","year":"2018","unstructured":"Langlois P.L.; Szwec C.; D\u2019Aragon F.; Heyland D.K.; Manzanares W.; Vitamin D supplementation in the critically ill: A systematic review and meta-analysis. Clin Nutr 2018,37(4),1238-1246","journal-title":"Clin Nutr"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"172889","DOI":"10.1016\/j.ejphar.2019.172889","volume":"868","author":"Wei X.B.","year":"2020","unstructured":"Wei X.B.; Wang Z.H.; Liao X.L.; Guo W.X.; Wen J.Y.; Qin T.H.; Wang S.H.; Efficacy of vitamin C in patients with sepsis: an updated meta-analysis. Eur J Pharmacol 2020,868,172889","journal-title":"Eur J Pharmacol"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1002\/fsn3.2003","volume":"9","author":"Workneh Bitew Z.","year":"2020","unstructured":"Workneh Bitew Z.; Worku T.; Alemu A.; Effects of vitamin D on neonatal sepsis: a systematic review and meta-analysis. Food Sci Nutr 2020,9(1),375-388","journal-title":"Food Sci Nutr"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1186\/s13054-014-0660-4","volume":"18","author":"de Haan K.","year":"2014","unstructured":"de Haan K.; Groeneveld A.B.; de Geus H.R.; Egal M.; Struijs A.; Vitamin D deficiency as a risk factor for infection, sepsis and mortality in the critically ill: systematic review and meta-analysis. Crit Care 2014,18(6),660","journal-title":"Crit Care"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/s12871-015-0063-3","volume":"15","author":"Upala S.","year":"2015","unstructured":"Upala S.; Sanguankeo A.; Permpalung N.; Significant association between vitamin D deficiency and sepsis: a systematic review and meta-analysis. BMC Anesthesiol 2015,15(1),84","journal-title":"BMC Anesthesiol"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"648442","DOI":"10.3389\/fnut.2021.648442","volume":"8","author":"Dang H.","year":"2021","unstructured":"Dang H.; Li J.; Liu C.; Xu F.; The association between vitamin E deficiency and critically Ill children with sepsis and septic shock. Front Nutr 2021,8,648442","journal-title":"Front Nutr"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1002\/iub.1976","volume":"71","author":"Lewis E.D.","year":"2019","unstructured":"Lewis E.D.; Meydani S.N.; Wu D.; Regulatory role of vitamin E in the immune system and inflammation. IUBMB Life 2019,71(4),487-494","journal-title":"IUBMB Life"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"86","DOI":"10.4103\/IJCIIS.IJCIIS_159_20","volume":"11","author":"Kanchanasurakit S.","year":"2021","unstructured":"Kanchanasurakit S.; Suthumpoung P.; Santimaleeworagun W.; Nakaranurack C.; Huynh N.S.; Srisawat C.; Nunta M.; Chirakan V.; Saokaew S.; Effectiveness of thiamine therapy in mortality rate in patients with septic shock: A systematic review and meta-analysis. Int J Crit Illn Inj Sci 2021,11(2),86-94","journal-title":"Int J Crit Illn Inj Sci"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"15777","DOI":"10.1038\/s41598-021-95386-9","volume":"11","author":"Fong K.M.","year":"2021","unstructured":"Fong K.M.; Au S.Y.; Ng G.W.Y.; Steroid, ascorbic acid, and thiamine in adults with sepsis and septic shock: a systematic review and component network meta-analysis. Sci Rep 2021,11(1),15777","journal-title":"Sci Rep"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1097\/TA.0000000000002613","volume":"89","author":"Byerly S.","year":"2020","unstructured":"Byerly S.; Parreco J.P.; Soe-Lin H.; Parks J.J.; Lee E.E.; Shnaydman I.; Mantero A.; Yeh D.D.; Namias N.; Rattan R.; Vitamin C and thiamine are associated with lower mortality in sepsis. J Trauma Acute Care Surg 2020,89(1),111-117","journal-title":"J Trauma Acute Care Surg"},{"key":"ref=63","volume":"22","author":"Harun N.F.","year":"2019","unstructured":"Harun N.F.; Intravenous thiamine as an adjuvant therapy for hyperlactatemia in septic shock patients. Crit Care Shock 2019,22(6)","journal-title":"Crit Care Shock"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"2718","DOI":"10.1016\/j.ajem.2020.08.050","volume":"38","author":"Qian X.","year":"2020","unstructured":"Qian X.; Zhang Z.; Li F.; Wu L.; Intravenous thiamine for septic shock: A meta-analysis of randomized controlled trials. Am J Emerg Med 2020,38(12),2718-2722","journal-title":"Am J Emerg Med"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"1820","DOI":"10.1128\/IAI.72.3.1820-1823.2004","volume":"72","author":"Toyosawa T.","year":"2004","unstructured":"Toyosawa T.; Suzuki M.; Kodama K.; Araki S.; Highly purified vitamin B2 presents a promising therapeutic strategy for sepsis and septic shock. Infect Immun 2004,72(3),1820-1823","journal-title":"Infect Immun"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.ejphar.2004.04.004","volume":"492","author":"Toyosawa T.","year":"2004","unstructured":"Toyosawa T.; Suzuki M.; Kodama K.; Araki S.; Effects of intravenous infusion of highly purified vitamin B2 on lipopolysaccharide-induced shock and bacterial infection in mice. Eur J Pharmacol 2004,492(2-3),273-280","journal-title":"Eur J Pharmacol"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/j.burns.2016.09.023","volume":"43","author":"Prauchner C.A.","year":"2017","unstructured":"Prauchner C.A.; Oxidative stress in sepsis: Pathophysiological implications justifying antioxidant co-therapy. Burns 2017,43(3),471-485","journal-title":"Burns"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.freeradbiomed.2018.05.073","volume":"123","author":"Hong G.","year":"2018","unstructured":"Hong G.; Zheng D.; Zhang L.; Ni R.; Wang G.; Fan G.C.; Lu Z.; Peng T.; Administration of nicotinamide riboside prevents oxidative stress and organ injury in sepsis. Free Radic Biol Med 2018,123,125-137","journal-title":"Free Radic Biol Med"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"5255","DOI":"10.1007\/s12035-017-0706-0","volume":"55","author":"Danielski L.G.","year":"2018","unstructured":"Danielski L.G.; Giustina A.D.; Goldim M.P.; Florentino D.; Mathias K.; Garbossa L.; de Bona Schraiber R.; Laurentino A.O.M.; Goulart M.; Michels M.; de Queiroz K.B.; Kohlhof M.; Rezin G.T.; Fortunato J.J.; Quevedo J.; Barichello T.; Dal-Pizzol F.; Coimbra R.S.; Petronilho F.; Vitamin B 6 reduces neurochemical and long-term cognitive alterations after Polymicrobial Sepsis: involvement of the kynurenine pathway modulation. Mol Neurobiol 2018,55(6),5255-5268","journal-title":"Mol Neurobiol"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"R713","DOI":"10.1016\/j.cub.2017.05.064","volume":"27","author":"Vickers N.J.","year":"2017","unstructured":"Vickers N.J.; Animal communication: when i\u2019m calling you, will you answer too? Curr Biol 2017,27(14),R713-R715","journal-title":"Curr Biol"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1086\/650996","volume":"201","author":"Tattevin P.","year":"2010","unstructured":"Tattevin P.; Monnier D.; Tribut O.; Dulong J.; Bescher N.; Mourcin F.; Uhel F.; Le Tulzo Y.; Tarte K.; Enhanced indoleamine 2,3-dioxygenase activity in patients with severe sepsis and septic shock. J Infect Dis 2010,201(6),956-966","journal-title":"J Infect Dis"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1186\/s13054-018-2102-1","volume":"22","author":"Lambden S.","year":"2018","unstructured":"Lambden S.; Creagh-Brown B.C.; Hunt J.; Summers C.; Forni L.G.; Definitions and pathophysiology of vasoplegic shock. Crit Care 2018,22(1),174","journal-title":"Crit Care"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1002\/ncp.10327","volume":"34","author":"Patel J.J.","year":"2019","unstructured":"Patel J.J.; Venegas-Borsellino C.; Willoughby R.; Freed J.K.; High-dose vitamin B12 in vasodilatory shock: a narrative review. Nutr Clin Pract 2019,34(4),514-520","journal-title":"Nutr Clin Pract"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1177\/0310057X1604400410","volume":"44","author":"Romain M.","year":"2016","unstructured":"Romain M.; Sviri S.; Linton D.M.; Stav I.; van Heerden P.V.; The role of Vitamin B12 in the critically ill-a review. Anaesth Intensive Care 2016,44(4),447-452","journal-title":"Anaesth Intensive Care"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.meatsci.2007.06.011","volume":"78","author":"Rigault C.","year":"2008","unstructured":"Rigault C.; Mazu\u00e9 F.; Bernard A.; Demarquoy J.; Le Borgne F.; Changes in l-carnitine content of fish and meat during domestic cooking. Meat Sci 2008,78(3),331-335","journal-title":"Meat Sci"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1006\/abbi.1996.0203","volume":"329","author":"Tein I.","year":"1996","unstructured":"Tein I.; Bukovac S.W.; Xie Z-W.; Characterization of the human plasmalemmal carnitine transporter in cultured skin fibroblasts. Arch Biochem Biophys 1996,329(2),145-155","journal-title":"Arch Biochem Biophys"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1042\/bj3610417","volume":"361","author":"Vaz F.M.","year":"2002","unstructured":"Vaz F.M.; Wanders R.J.; Carnitine biosynthesis in mammals. Biochem J 2002,361(Pt 3),417-429","journal-title":"Biochem J"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"2127","DOI":"10.3390\/molecules25092127","volume":"25","author":"Durazzo A.","year":"2020","unstructured":"Durazzo A.; Lucarini M.; Nazhand A.; Souto S.B.; Silva A.M.; Severino P.; Souto E.B.; Santini A.; The nutraceutical value of carnitine and its use in dietary supplements. Molecules 2020,25(9),2127","journal-title":"Molecules"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1113\/jphysiol.2006.125799","volume":"581","author":"Stephens F.B.","year":"2007","unstructured":"Stephens F.B.; Constantin-Teodosiu D.; Greenhaff P.L.; New insights concerning the role of carnitine in the regulation of fuel metabolism in skeletal muscle. J Physiol 2007,581(Pt 2),431-444","journal-title":"J Physiol"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1016\/j.addr.2009.06.009","volume":"61","author":"Rosca M.G.","year":"2009","unstructured":"Rosca M.G.; Lemieux H.; Hoppel C.L.; Mitochondria in the elderly: is acetylcarnitine a rejuvenator? Adv Drug Deliv Rev 2009,61(14),1332-1342","journal-title":"Adv Drug Deliv Rev"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1016\/j.euroneuro.2012.11.013","volume":"23","author":"Bersani G.","year":"2013","unstructured":"Bersani G.; Meco G.; Denaro A.; Liberati D.; Colletti C.; Nicolai R.; Bersani F.S.; Koverech A.; L-Acetylcarnitine in dysthymic disorder in elderly patients: a double-blind, multicenter, controlled randomized study vs. fluoxetine. Eur Neuropsychopharmacol 2013,23(10),1219-1225","journal-title":"Eur Neuropsychopharmacol"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/j.nut.2004.04.003","volume":"20","author":"Karlic H.","year":"2004","unstructured":"Karlic H.; Lohninger A.; Supplementation of L-carnitine in athletes: does it make sense? Nutrition 2004,20(7-8),709-715","journal-title":"Nutrition"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1519\/JSC.0b013e3182a76790","volume":"28","author":"Orer G.E.","year":"2014","unstructured":"Orer G.E.; Guzel N.A.; The effects of acute L-carnitine supplementation on endurance performance of athletes. J Strength Cond Res 2014,28(2),514-519","journal-title":"J Strength Cond Res"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1007\/BF00334420","volume":"73","author":"Colombani P.","year":"1996","unstructured":"Colombani P.; Wenk C.; Kunz I.; Kr\u00e4henb\u00fchl S.; Kuhnt M.; Arnold M.; Frey-Rindova P.; Frey W.; Langhans W.; Effects of L-carnitine supplementation on physical performance and energy metabolism of endurance-trained athletes: a double-blind crossover field study. Eur J Appl Physiol Occup Physiol 1996,73(5),434-439","journal-title":"Eur J Appl Physiol Occup Physiol"},{"key":"ref=85","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1249\/01.mss.0000227314.85728.35","volume":"38","author":"Kraemer W.J.","year":"2006","unstructured":"Kraemer W.J.; Spiering B.A.; Volek J.S.; Ratamess N.A.; Sharman M.J.; Rubin M.R.; French D.N.; Silvestre R.; Hatfield D.L.; Van Heest J.L.; Vingren J.L.; Judelson D.A.; Deschenes M.R.; Maresh C.M.; Androgenic responses to resistance exercise: effects of feeding and L-carnitine. Med Sci Sports Exerc 2006,38(7),1288-1296","journal-title":"Med Sci Sports Exerc"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1007\/s00706-005-0322-y","volume":"136","author":"Kraemer W.J.","year":"2005","unstructured":"Kraemer W.J.; L-carnitine supplementation: a new paradigm for its role in exercise. Monatshefte f\u00fcr Chemie\/Chemical Monthly 2005,136(8),1383-1390","journal-title":"Monatshefte f\u00fcr Chemie\/Chemical Monthly"},{"key":"ref=87","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1519\/JSC.0b013e31817d48d9","volume":"22","author":"Spiering B.A.","year":"2008","unstructured":"Spiering B.A.; Kraemer W.J.; Hatfield D.L.; Vingren J.L.; Fragala M.S.; Ho J.Y.; Thomas G.A.; H\u00e4kkinen K.; Volek J.S.; Effects of L-carnitine L-tartrate supplementation on muscle oxygenation responses to resistance exercise. J Strength Cond Res 2008,22(4),1130-1135","journal-title":"J Strength Cond Res"},{"key":"ref=88","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s12986-016-0158-y","volume":"14","author":"Evans M.","year":"2017","unstructured":"Evans M.; Guthrie N.; Pezzullo J.; Sanli T.; Fielding R.A.; Bellamine A.; Efficacy of a novel formulation of L- Carnitine, creatine, and leucine on lean body mass and functional muscle strength in healthy older adults: a randomized, double-blind placebo-controlled study. Nutr Metab (Lond) 2017,14(1),7","journal-title":"Nutr Metab (Lond)"},{"key":"ref=89","doi-asserted-by":"publisher","first-page":"349","DOI":"10.3390\/nu10030349","volume":"10","author":"Fielding R.","year":"2018","unstructured":"Fielding R.; Riede L.; Lugo J.P.; Bellamine A.; L-carnitine supplementation in recovery after exercise. Nutrients 2018,10(3),349","journal-title":"Nutrients"},{"key":"ref=90","doi-asserted-by":"publisher","first-page":"e8","DOI":"10.1017\/jns.2017.4","volume":"6","author":"Varney J.L.","year":"2017","unstructured":"Varney J.L.; Fowler J.W.; Gilbert W.C.; Coon C.N.; Utilisation of supplemented l-carnitine for fuel efficiency, as an antioxidant, and for muscle recovery in Labrador retrievers. J Nutr Sci 2017,6,e8","journal-title":"J Nutr Sci"},{"key":"ref=91","doi-asserted-by":"publisher","first-page":"3104","DOI":"10.2527\/2001.79123104x","volume":"79","author":"Owen K.Q.","year":"2001","unstructured":"Owen K.Q.; Jit H.; Maxwell C.V.; Nelssen J.L.; Goodband R.D.; Tokach M.D.; Tremblay G.C.; Koo S.I.; Dietary L-carnitine suppresses mitochondrial branched-chain keto acid dehydrogenase activity and enhances protein accretion and carcass characteristics of swine. J Anim Sci 2001,79(12),3104-3112","journal-title":"J Anim Sci"},{"key":"ref=92","doi-asserted-by":"publisher","first-page":"2696","DOI":"10.3390\/nu12092696","volume":"12","author":"Calder P.C.","year":"2020","unstructured":"Calder P.C.; Carr A.C.; Gombart A.F.; Eggersdorfer M.; Reply to \u201cOverstated Claims of Efficacy and Safety. Comment On: Optimal Nutritional Status for a Well-Functioning Immune System Is an Important Factor to Protect against Viral Infections. Nutrients 2020, 12, 1181\u201d. Nutrients 2020,12(9),2696","journal-title":"Nutrients"},{"key":"ref=93","author":"Childs C.E.","year":"2019","unstructured":"Childs C.E.; Calder P.C.; Miles E.A.;  Diet and immune function 2019","journal-title":"Diet and immune function"},{"key":"ref=94","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1007\/s00706-005-0333-8","volume":"136","author":"Alesci S.","year":"2005","unstructured":"Alesci S.; Gerschenson M.; Ilias I.; L-carnitine, immunomodulation, and human immunodeficiency virus (HIV)-related disorders. Monatshefte f\u00fcr Chemie\/Chemical Monthly 2005,136(8),1493-1500","journal-title":"Monatshefte f\u00fcr Chemie\/Chemical Monthly"},{"key":"ref=95","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/S0300-483X(03)00050-7","volume":"187","author":"Arafa H.M.","year":"2003","unstructured":"Arafa H.M.; Abd-Allah A.R.; El-Mahdy M.A.; Ramadan L.A.; Hamada F.M.; Immunomodulatory effects of L- carnitine and q10 in mouse spleen exposed to low-frequency high-intensity magnetic field. Toxicology 2003,187(2-3),171-181","journal-title":"Toxicology"},{"key":"ref=96","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.cca.2007.11.013","volume":"389","author":"Thangasamy T.","year":"2008","unstructured":"Thangasamy T.; Subathra M.; Sittadjody S.; Jeyakumar P.; Joyee A.G.; Mendoza E.; Chinnakkanu P.; Role of L- carnitine in the modulation of immune response in aged rats. Clin Chim Acta 2008,389(1-2),19-24","journal-title":"Clin Chim Acta"},{"key":"ref=97","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1007\/BF03324561","volume":"16","author":"Izg\u00fct-Uysal V.N.","year":"2004","unstructured":"Izg\u00fct-Uysal V.N.; Aga\u00e7 A.; Karadogan I.; Derin N.; Peritoneal macrophages function modulation by L-carnitine in aging rats. Aging Clin Exp Res 2004,16(5),337-341","journal-title":"Aging Clin Exp Res"},{"key":"ref=98","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1172\/JCI64096","volume":"123","author":"Montecino-Rodriguez E.","year":"2013","unstructured":"Montecino-Rodriguez E.; Berent-Maoz B.; Dorshkind K.; Causes, consequences, and reversal of immune system aging. J Clin Invest 2013,123(3),958-965","journal-title":"J Clin Invest"},{"key":"ref=99","doi-asserted-by":"publisher","first-page":"116607","DOI":"10.1016\/j.lfs.2019.116607","volume":"232","author":"Haghi Aminjan H.","year":"2019","unstructured":"Haghi Aminjan H.; Abtahi S.R.; Hazrati E.; Chamanara M.; Jalili M.; Paknejad B.; Targeting of oxidative stress and inflammation through ROS\/NF-kappaB pathway in phosphine-induced hepatotoxicity mitigation. Life Sci 2019,232,116607","journal-title":"Life Sci"},{"key":"ref=100","first-page":"53","volume":"10","author":"Franceschi C.","year":"1990","unstructured":"Franceschi C.; Cossarizza A.; Troiano L.; Salati R.; Monti D.; Immunological parameters in aging: studies on natural immunomodulatory and immunoprotective substances. Int J Clin Pharmacol Res 1990,10(1-2),53-57","journal-title":"Int J Clin Pharmacol Res"},{"key":"ref=101","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1111\/j.1582-4934.2008.00342.x","volume":"13","author":"Hao J.","year":"2009","unstructured":"Hao J.; Shen W.; Tian C.; Liu Z.; Ren J.; Luo C.; Long J.; Sharman E.; Liu J.; Mitochondrial nutrients improve immune dysfunction in the type 2 diabetic Goto-Kakizaki rats. J Cell Mol Med 2009,13(4),701-711","journal-title":"J Cell Mol Med"},{"key":"ref=102","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s10565-006-0025-0","volume":"22","author":"\u015eener G.","year":"2006","unstructured":"\u015eener G.; Ek\u015fio\u011flu-Demiralp E.; Cetiner M.; Ercan F.; Sirvanci S.; Gedik N.; Ye\u011fen B.C.; L-Carnitine ameliorates methotrexate-induced oxidative organ injury and inhibits leukocyte death. Cell Biol Toxicol 2006,22(1),47-60","journal-title":"Cell Biol Toxicol"},{"key":"ref=103","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/726158","volume":"2014","author":"Diodato M.","year":"2014","unstructured":"Diodato M.; Chedrawy E.G.; Chedrawy, Coronary artery bypass graft surgery: the past, present, and future of myocardial revascularisation. Surgery Res Practice 2014,2014","journal-title":"Surgery Res Practice"},{"key":"ref=104","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.9738\/INTSURG-D-15-00071.1","volume":"100","author":"Aldemir M.","year":"2015","unstructured":"Aldemir M.; Pekta\u015f M.B.; Parlar A.\u0130.; Akc\u0131 \u00d6.; Emren S.V.; Tecer E.; Adal\u0131 F.; Y\u00fcksel \u015e.; Dar\u00e7\u0131n O.T.; L-carnitine supplementation reduces short-term neutrophil-lymphocyte ratio in patients undergoing coronary artery bypass grafting. Int Surg 2015,100(7-8),1160-1168","journal-title":"Int Surg"},{"key":"ref=105","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/B978-0-12-386454-3.00345-6","author":"Shankar K.","year":"2014","unstructured":"Shankar K.; Mehendale H.M.; Oxidative stress. Encycl Toxicol 2014,735-737","journal-title":"Encycl Toxicol"},{"key":"ref=106","doi-asserted-by":"publisher","DOI":"10.5772\/intechopen.83544","author":"Aziz M.A.","year":"2019","unstructured":"Aziz M.A.; Diab A.S.; Mohammed A.A.; Antioxidant Categories and Mode of Action Antioxidants 2019","journal-title":"Antioxidants"},{"key":"ref=107","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1016\/j.lfs.2005.05.103","volume":"78","author":"G\u00fcl\u00e7in I.","year":"2006","unstructured":"G\u00fcl\u00e7in I.; Antioxidant and antiradical activities of L-carnitine. Life Sci 2006,78(8),803-811","journal-title":"Life Sci"},{"key":"ref=108","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/j.nut.2010.06.009","volume":"27","author":"Kolodziejczyk J.","year":"2011","unstructured":"Kolodziejczyk J.; Saluk-Juszczak J.; Wachowicz B.; L- Carnitine protects plasma components against oxidative alterations. Nutrition 2011,27(6),693-699","journal-title":"Nutrition"},{"key":"ref=109","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1097\/00005344-200405000-00013","volume":"43","author":"\u015eener G.","year":"2004","unstructured":"\u015eener G.; Paskalo\u011flu K.; Satiroglu H.; Alican I.; Ka\u00e7maz A.; Sakarcan A.; L-carnitine ameliorates oxidative damage due to chronic renal failure in rats. J Cardiovasc Pharmacol 2004,43(5),698-705","journal-title":"J Cardiovasc Pharmacol"},{"key":"ref=110","doi-asserted-by":"publisher","first-page":"e0204913","DOI":"10.1371\/journal.pone.0204913","volume":"13","author":"Al-Eisa R.A.","year":"2018","unstructured":"Al-Eisa R.A.; Al-Salmi F.A.; Hamza R.Z.; El-Shenawy N.S.; Role of L-carnitine in protection against the cardiac oxidative stress induced by aspartame in Wistar albino rats. PLoS One 2018,13(11),e0204913","journal-title":"PLoS One"},{"key":"ref=111","first-page":"66","volume":"2","author":"Surai P.F.","year":"2015","unstructured":"Surai P.F.; Antioxidant action of carnitine: molecular mechanisms and practical applications. EC Vet Sci 2015,2(1),66-84","journal-title":"EC Vet Sci"},{"key":"ref=112","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/1423-0127-19-32","volume":"19","author":"Li J-L.","year":"2012","unstructured":"Li J-L.; Wang Q.Y.; Luan H.Y.; Kang Z.C.; Wang C.B.; Effects of L-carnitine against oxidative stress in human hepatocytes: involvement of peroxisome proliferator-activated receptor alpha. J Biomed Sci 2012,19(1),32","journal-title":"J Biomed Sci"},{"key":"ref=113","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/ejcn.2017.131","volume":"72","author":"Mohammadi H.","year":"2017","unstructured":"Mohammadi H.; Djalali M.; Daneshpazhooh M.; Honarvar N.M.; Chams-Davatchi C.; Sepandar F.; Fakhri Z.; Yaghubi E.; Zarei M.; Javanbakht M.H.; Effects of L-carnitine supplementation on biomarkers of oxidative stress, antioxidant capacity and lipid profile, in patients with pemphigus vulgaris: a randomized, double-blind, placebo-controlled trial. Eur J Clin Nutr 2017,72(1),99-104","journal-title":"Eur J Clin Nutr"},{"key":"ref=114","doi-asserted-by":"publisher","DOI":"10.1155\/2007\/72741","volume":"2007","author":"Rajasekar P.","year":"2007","unstructured":"Rajasekar P.; Anuradha C.V.; Effect of L-carnitine on skeletal muscle lipids and oxidative stress in rats fed high- fructose diet. Experim Diabet Res 2007,2007","journal-title":"Experim Diabet Res"},{"key":"ref=115","first-page":"419","volume":"26","author":"Uysal N.","year":"2005","unstructured":"Uysal N.; Yalaz G.; Acikgoz O.; Gonenc S.; Kayatekin B.M.; Effect of L-carnitine on diabetogenic action of streptozotocin in rats. Neuroendocrinol Lett 2005,26(4),419-422","journal-title":"Neuroendocrinol Lett"},{"key":"ref=116","doi-asserted-by":"publisher","first-page":"90","DOI":"10.2478\/s11658-009-0036-y","volume":"15","author":"Solarska K.","year":"2010","unstructured":"Solarska K.; Lewi\u0144ska A.; Karowicz-Bili\u0144ska A.; Bartosz G.; The antioxidant properties of carnitine in vitro. Cell Mol Biol Lett 2010,15(1),90-97","journal-title":"Cell Mol Biol Lett"},{"key":"ref=117","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/j.gene.2013.10.017","volume":"533","author":"Ribas G.S.","year":"2014","unstructured":"Ribas G.S.; Vargas C.R.; Wajner M.; L-carnitine supplementation as a potential antioxidant therapy for inherited neurometabolic disorders. Gene 2014,533(2),469-476","journal-title":"Gene"},{"key":"ref=118","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.1007\/s40200-020-00627-9","volume":"19","author":"Fathizadeh H.","year":"2020","unstructured":"Fathizadeh H.; Milajerdi A.; Reiner \u017d.; Amirani E.; Asemi Z.; Mansournia M.A.; Hallajzadeh J.; The effects of L-carnitine supplementation on indicators of inflammation and oxidative stress: a systematic review and meta-analysis of randomized controlled trials. J Diabetes Metab Disord 2020,19(2),1879-1894","journal-title":"J Diabetes Metab Disord"},{"key":"ref=119","doi-asserted-by":"publisher","first-page":"BR1","DOI":"10.12659\/MSM.881311","volume":"17","author":"Jing L.","year":"2011","unstructured":"Jing L.; Zhou L.J.; Li W.M.; Zhang F.M.; Yuan L.; Li S.; Song J.; Sang Y.; Carnitine regulates myocardial metabolism by Peroxisome Proliferator-Activated Receptor-\u03b1 (PPARalpha) in alcoholic cardiomyopathy. Med Sci Monit 2011,17(1),BR1-BR9","journal-title":"Med Sci Monit"},{"key":"ref=120","doi-asserted-by":"publisher","first-page":"83","DOI":"10.2165\/00126839-200809020-00003","volume":"9","author":"Broderick T.L.","year":"2008","unstructured":"Broderick T.L.; ATP production and TCA activity are stimulated by propionyl-L-carnitine in the diabetic rat heart. Drugs R D 2008,9(2),83-91","journal-title":"Drugs R D"},{"key":"ref=121","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/S0168-8227(01)00240-6","volume":"53","author":"Felix C.","year":"2001","unstructured":"Felix C.; Gillis M.; Driedzic W.R.; Paulson D.J.; Broderick T.L.; Effects of propionyl-L-carnitine on isolated mitochondrial function in the reperfused diabetic rat heart. Diabetes Res Clin Pract 2001,53(1),17-24","journal-title":"Diabetes Res Clin Pract"},{"key":"ref=122","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.ijcard.2005.02.053","volume":"107","author":"Cal\u00f2 L.A.","year":"2006","unstructured":"Cal\u00f2 L.A.; Pagnin E.; Davis P.A.; Semplicini A.; Nicolai R.; Calvani M.; Pessina A.C.; Antioxidant effect of L- carnitine and its short chain esters: relevance for the protection from oxidative stress related cardiovascular damage. Int J Cardiol 2006,107(1),54-60","journal-title":"Int J Cardiol"},{"key":"ref=123","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1023\/A:1024984013069","volume":"28","author":"Calabrese V.","year":"2003","unstructured":"Calabrese V.; Scapagnini G.; Ravagna A.; Bella R.; Butterfield D.A.; Calvani M.; Pennisi G.; Giuffrida Stella A.M.; Disruption of thiol homeostasis and nitrosative stress in the cerebrospinal fluid of patients with active multiple sclerosis: evidence for a protective role of acetylcarnitine. Neurochem Res 2003,28(9),1321-1328","journal-title":"Neurochem Res"},{"key":"ref=124","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1159\/000477419","volume":"9","author":"Genga K.R.","year":"2017","unstructured":"Genga K.R.; Russell J.A.; Update of sepsis in the intensive care unit. J Innate Immun 2017,9(5),441-455","journal-title":"J Innate Immun"},{"key":"ref=125","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.3390\/nu13041219","volume":"13","author":"Takashima H.","year":"2021","unstructured":"Takashima H.; Maruyama T.; Abe M.; Significance of levocarnitine treatment in dialysis patients. Nutrients 2021,13(4),1219","journal-title":"Nutrients"},{"key":"ref=126","first-page":"890","volume":"26","author":"Zhou Z.","year":"2014","unstructured":"Zhou Z.; Qiu C.; Chen C.; Wang L.; Chen J.; Chen M.; Guan X.; Ouyang B.; Related factor of serum carnitine deficiency and influence of its deficiency on the length of hospital stay in critical ill patients. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue 2014,26(12),890-894","journal-title":"Zhonghua Wei Zhong Bing Ji Jiu Yi Xue"},{"key":"ref=127","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s41100-018-0158-7","volume":"4","author":"Oami T.","year":"2018","unstructured":"Oami T.; L-Carnitine in critically ill patients - a case series study. Renal Replacement Ther 2018,4(1),1-8","journal-title":"Renal Replacement Ther"},{"key":"ref=128","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/0026-0495(92)90146-2","volume":"41","author":"Wennberg A.","year":"1992","unstructured":"Wennberg A.; Hyltander A.; Sj\u00f6berg A.; Arfvidsson B.; Sandstr\u00f6m R.; Wickstr\u00f6m I.; Lundholm K.; Prevalence of carnitine depletion in critically ill patients with undernutrition. Metabolism 1992,41(2),165-171","journal-title":"Metabolism"},{"key":"ref=129","doi-asserted-by":"publisher","first-page":"R184","DOI":"10.1186\/cc8172","volume":"13","author":"Santiago M.J.","year":"2009","unstructured":"Santiago M.J.; L\u00f3pez-Herce J.; Urbano J.; Solana M.J.; del Castillo J.; Ballestero Y.; Botr\u00e1n M.; Bell\u00f3n J.M.; Complications of continuous renal replacement therapy in critically ill children: a prospective observational evaluation study. Crit Care 2009,13(6),R184","journal-title":"Crit Care"},{"key":"ref=130","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1097\/MCO.0000000000000037","volume":"17","author":"Bonaf\u00e9 L.","year":"2014","unstructured":"Bonaf\u00e9 L.; Berger M.M.; Que Y.A.; Mechanick J.I.; Carnitine deficiency in chronic critical illness. Curr Opin Clin Nutr Metab Care 2014,17(2),200-209","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"ref=131","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1007\/s12029-013-9497-3","volume":"44","author":"Rabito E.I.","year":"2013","unstructured":"Rabito E.I.; Leme I.A.; Demenice R.; Portari G.V.; Jord\u00e3o A.A.; dos Santos J.S.; Marchini J.S.; Lower carnitine plasma values from malnutrition cancer patients. J Gastrointest Cancer 2013,44(3),362-365","journal-title":"J Gastrointest Cancer"},{"key":"ref=132","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/j.anl.2018.10.007","volume":"46","author":"Endo K.","year":"2019","unstructured":"Endo K.; Ueno T.; Ishikawa K.; Nakanishi Y.; Kondo S.; Wakisaka N.; Yoshizaki T.; Effects of l-carnitine administration on health-related quality of life during cisplatin-based chemoradiotherapy in patients with head and neck squamous cell carcinoma. Auris Nasus Larynx 2019,46(3),431-436","journal-title":"Auris Nasus Larynx"},{"key":"ref=133","author":"Hooke M.C.","year":"2009","unstructured":"Hooke M.C.;  Fatigue, physical performance, and carnitine levels in children and adolescents receiving chemotherapy 2009","journal-title":"Fatigue, physical performance, and carnitine levels in children and adolescents receiving chemotherapy"},{"key":"ref=134","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1007\/s00520-015-2824-4","volume":"24","author":"Iwase S.","year":"2016","unstructured":"Iwase S.; Kawaguchi T.; Yotsumoto D.; Doi T.; Miyara K.; Odagiri H.; Kitamura K.; Ariyoshi K.; Miyaji T.; Ishiki H.; Inoue K.; Tsutsumi C.; Sagara Y.; Yamaguchi T.; Efficacy and safety of an amino acid jelly containing coenzyme Q10 and L-carnitine in controlling fatigue in breast cancer patients receiving chemotherapy: A multi-institutional, randomized, exploratory trial (JORTC- CAM01). Support Care Cancer 2016,24(2),637-646","journal-title":"Support Care Cancer"},{"key":"ref=135","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/1475-2891-11-52","volume":"11","author":"Kraft M.","year":"2012","unstructured":"Kraft M.; Kraft K.; G\u00e4rtner S.; Mayerle J.; Simon P.; Weber E.; Sch\u00fctte K.; Stieler J.; Koula-Jenik H.; Holzhauer P.; Gr\u00f6ber U.; Engel G.; M\u00fcller C.; Feng Y.S.; Aghdassi A.; Nitsche C.; Malfertheiner P.; Patrzyk M.; Kohlmann T.; Lerch M.M.; L-Carnitine-supplementation in advanced pancreatic cancer (CARPAN)-a randomized multicentre trial. Nutr J 2012,11(1),52","journal-title":"Nutr J"},{"key":"ref=136","doi-asserted-by":"publisher","first-page":"8","DOI":"10.12688\/f1000research.17376.1","volume":"8","author":"Piva S.","year":"2019","unstructured":"Piva S.; Fagoni N.; Latronico N.; Intensive care unit-acquired weakness: unanswered questions and targets for future research. F1000 Res 2019,8,8","journal-title":"F1000 Res"},{"key":"ref=137","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13613-019-0618-4","volume":"10","author":"Saccheri C.","year":"2020","unstructured":"Saccheri C.; Morawiec E.; Delemazure J.; Mayaux J.; Dub\u00e9 B.P.; Similowski T.; Demoule A.; Dres M.; ICU-acquired weakness, diaphragm dysfunction and long-term outcomes of critically ill patients. Ann Intensive Care 2020,10(1),1","journal-title":"Ann Intensive Care"},{"key":"ref=138","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1007\/s00101-011-1951-7","volume":"60","author":"Judemann K.","year":"2011","unstructured":"Judemann K.; Lunz D.; Zausig Y.A.; Graf B.M.; Zink W.; Intensive care unit-acquired weakness in the critically ill : critical illness polyneuropathy and critical illness myopathy. Anaesthesist 2011,60(10),887-901","journal-title":"Anaesthesist"},{"key":"ref=139","doi-asserted-by":"publisher","first-page":"406","DOI":"10.5455\/aim.2014.22.406-410","volume":"22","author":"Koukourikos K.","year":"2014","unstructured":"Koukourikos K.; Tsaloglidou A.; Kourkouta L.; Muscle atrophy in intensive care unit patients. Acta Inform Med 2014,22(6),406-410","journal-title":"Acta Inform Med"},{"key":"ref=140","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1111\/j.1542-4758.2012.00679.x","volume":"16","author":"Cal\u00f2 L.A.","year":"2012","unstructured":"Cal\u00f2 L.A.; Vertolli U.; Davis P.A.; Savica V.; L carnitine in hemodialysis patients. Hemodial Int 2012,16(3),428-434","journal-title":"Hemodial Int"},{"key":"ref=141","author":"Moukas M.","year":"2000","unstructured":"Moukas M.; Is muscular mass affected by L-Carnitine levels in critically ill patients? Critical Care 2000","journal-title":"Critical Care"},{"key":"ref=142","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s10741-006-9195-3","volume":"11","author":"Allard M.L.","year":"2006","unstructured":"Allard M.L.; Jeejeebhoy K.N.; Sole M.J.; The management of conditioned nutritional requirements in heart failure. Heart Fail Rev 2006,11(1),75-82","journal-title":"Heart Fail Rev"},{"key":"ref=143","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1196\/annals.1320.007","volume":"1033","author":"Ferrari R.","year":"2004","unstructured":"Ferrari R.; Merli E.; Cicchitelli G.; Mele D.; Fucili A.; Ceconi C.; Therapeutic effects of L-carnitine and propionyl-L-carnitine on cardiovascular diseases: a review. Ann NY Acad Sci 2004,1033(1),79-91","journal-title":"Ann NY Acad Sci"},{"key":"ref=144","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1161\/HYPERTENSIONAHA.109.132522","volume":"54","author":"Ruggenenti P.","year":"2009","unstructured":"Ruggenenti P.; Cattaneo D.; Loriga G.; Ledda F.; Motterlini N.; Gherardi G.; Orisio S.; Remuzzi G.; Ameliorating hypertension and insulin resistance in subjects at increased cardiovascular risk: effects of acetyl-L-carnitine therapy. Hypertension 2009,54(3),567-574","journal-title":"Hypertension"},{"key":"ref=145","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1016\/j.amjcard.2008.07.022","volume":"102","author":"Volek J.S.","year":"2008","unstructured":"Volek J.S.; Judelson D.A.; Silvestre R.; Yamamoto L.M.; Spiering B.A.; Hatfield D.L.; Vingren J.L.; Quann E.E.; Anderson J.M.; Maresh C.M.; Kraemer W.J.; Effects of carnitine supplementation on flow-mediated dilation and vascular inflammatory responses to a high-fat meal in healthy young adults. Am J Cardiol 2008,102(10),1413-1417","journal-title":"Am J Cardiol"},{"key":"ref=146","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1007\/s00726-010-0770-5","volume":"41","author":"Galloway S.D.","year":"2011","unstructured":"Galloway S.D.; Craig T.P.; Cleland S.J.; Effects of oral L-carnitine supplementation on insulin sensitivity indices in response to glucose feeding in lean and overweight\/obese males. Amino Acids 2011,41(2),507-515","journal-title":"Amino Acids"},{"key":"ref=147","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1159\/000301075","volume":"49","author":"Lohninger A.","year":"2009","unstructured":"Lohninger A.; Radler U.; Jinniate S.; Lohninger S.; Karlic H.; Lechner S.; Mascher D.; Tammaa A.; Salzer H.; Relationship between carnitine, fatty acids and insulin resistance. Gynakol Geburtshilfliche Rundsch 2009,49(4),230-235","journal-title":"Gynakol Geburtshilfliche Rundsch"},{"key":"ref=148","doi-asserted-by":"publisher","first-page":"761","DOI":"10.2165\/00002512-200320100-00004","volume":"20","author":"Pistone G.","year":"2003","unstructured":"Pistone G.; Marino A.; Leotta C.; Dell\u2019Arte S.; Finocchiaro G.; Malaguarnera M.; Levocarnitine administration in elderly subjects with rapid muscle fatigue: effect on body composition, lipid profile and fatigue. Drugs Aging 2003,20(10),761-767","journal-title":"Drugs Aging"},{"key":"ref=149","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1038\/sj.ejcn.1602109","volume":"59","author":"Rahbar A.R.","year":"2005","unstructured":"Rahbar A.R.; Shakerhosseini R.; Saadat N.; Taleban F.; Pordal A.; Gollestan B.; Effect of L-carnitine on plasma glycemic and lipidemic profile in patients with type II diabetes mellitus. Eur J Clin Nutr 2005,59(4),592-596","journal-title":"Eur J Clin Nutr"},{"key":"ref=150","doi-asserted-by":"publisher","first-page":"1726","DOI":"10.1212\/WNL.41.11.1726","volume":"41","author":"Spagnoli A.","year":"1991","unstructured":"Spagnoli A.; Lucca U.; Menasce G.; Bandera L.; Cizza G.; Forloni G.; Tettamanti M.; Frattura L.; Tiraboschi P.; Comelli M.; Long-term acetyl-L-carnitine treatment in Alzheimer\u2019s disease. Neurology 1991,41(11),1726-1732","journal-title":"Neurology"},{"key":"ref=151","doi-asserted-by":"crossref","first-page":"18","DOI":"10.4236\/jbbs.2012.21003","volume":"2","author":"Freddi R.","year":"2012","unstructured":"Freddi R.; Behaviour and Degenerative Changes in the Basal Forebrain Systems of Aged Rats (12 Months Old) after Levo-Acetyl-Carnitine Treatments. J Behav Brain Sci 2012,2(1),18-25","journal-title":"J Behav Brain Sci"},{"key":"ref=152","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1038\/bjc.1995.482","volume":"72","author":"Winter B.K.","year":"1995","unstructured":"Winter B.K.; Fiskum G.; Gallo L.L.; Effects of L-carnitine on serum triglyceride and cytokine levels in rat models of cachexia and septic shock. Br J Cancer 1995,72(5),1173-1179","journal-title":"Br J Cancer"},{"key":"ref=153","doi-asserted-by":"publisher","first-page":"334","DOI":"10.3109\/08941939.2015.1029652","volume":"28","author":"Ercan U.","year":"2015","unstructured":"Ercan U.; Kiraz A.; \u00c7ikman \u00d6.; T\u00fcrk\u00f6n H.; Kilin\u00e7 N.; Otkun M.T.; \u00d6zkan \u00d6.F.; Kiraz H.A.; Karaayvaz M.; The effect of systemic carnitine administration on colon anastomosis healing in an experimental sepsis model. J Invest Surg 2015,28(6),334-340","journal-title":"J Invest Surg"},{"key":"ref=154","doi-asserted-by":"publisher","first-page":"S43","DOI":"10.1155\/S0962935193000754","volume":"2","author":"Ruggiero V.","year":"1993","unstructured":"Ruggiero V.; D\u2019Urso C.M.; Albertoni C.; Campo S.; Foresta P.; Martelli E.A.; LPS-induced serum TNF production and lethality in mice: effect of L-carnitine and some acyl-derivatives. Mediators Inflamm 1993,2(7),S43-S50","journal-title":"Mediators Inflamm"},{"key":"ref=155","doi-asserted-by":"publisher","first-page":"S51","DOI":"10.1155\/S0962935193000766","volume":"2","author":"Gallo L.L.","year":"1993","unstructured":"Gallo L.L.; Tian Y.; Orfalian Z.; Fiskum G.; Amelioration of popolysaccharide-induced sepsis in rats by free and esterified carnitine. Mediators Inflamm 1993,2(7),S51-S56","journal-title":"Mediators Inflamm"},{"key":"ref=156","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1248\/bpb.19.157","volume":"19","author":"Hayashi N.","year":"1996","unstructured":"Hayashi N.; Yoshihara D.; Kashiwabara N.; Takeshita Y.; Handa H.; Yamakawa M.; Effect of carnitine on decrease of branched chain amino acids and glutamine in serum of septic rats. Biol Pharm Bull 1996,19(1),157-159","journal-title":"Biol Pharm Bull"},{"key":"ref=157","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1016\/0022-3468(95)90321-6","volume":"30","author":"Linz D.N.","year":"1995","unstructured":"Linz D.N.; Garcia V.F.; Arya G.; Hug G.; Tombragel E.; Landrigan E.; Chuck G.; Tsoras M.; Ryan M.; Ziegler M.M.; Weanling and adult rats differ in fatty acid and carnitine metabolism during sepsis. J Pediatr Surg 1995,30(7),959-965","journal-title":"J Pediatr Surg"},{"key":"ref=158","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/S0261-5614(96)80038-0","volume":"15","author":"Yamakawa M.","year":"1996","unstructured":"Yamakawa M.; Maeda J.; Nakamura T.; Mimura Y.; Sugisaki K.; Fujita T.; Hayashi N.; Kondo Y.; Oohara T.; Distribution of endogenous and exogenous carnitine in rats with sepsis and acute liver failure. Clin Nutr 1996,15(3),133-140","journal-title":"Clin Nutr"},{"key":"ref=159","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1007\/s00394-012-0470-x","volume":"52","author":"Zambrano S.","year":"2013","unstructured":"Zambrano S.; Blanca A.J.; Ruiz-Armenta M.V.; Miguel- Carrasco J.L.; Revilla E.; Santa-Mar\u00eda C.; Mate A.; V\u00e1zquez C.M.; The renoprotective effect of L-carnitine in hypertensive rats is mediated by modulation of oxidative stress-related gene expression. Eur J Nutr 2013,52(6),1649-1659","journal-title":"Eur J Nutr"},{"key":"ref=160","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1111\/j.1475-097X.1984.tb00811.x","volume":"4","author":"Carlsson M.","year":"1984","unstructured":"Carlsson M.; Forsberg E.; Th\u00f6rne A.; Observations during L-carnitine infusion in two long-term critically ill patients. Clin Physiol 1984,4(4),363-365","journal-title":"Clin Physiol"},{"key":"ref=161","doi-asserted-by":"publisher","first-page":"e186076","DOI":"10.1001\/jamanetworkopen.2018.6076","volume":"1","author":"Jones A.E.","year":"2018","unstructured":"Jones A.E.; Puskarich M.A.; Shapiro N.I.; Guirgis F.W.; Runyon M.; Adams J.Y.; Sherwin R.; Arnold R.; Roberts B.W.; Kurz M.C.; Wang H.E.; Kline J.A.; Courtney D.M.; Trzeciak S.; Sterling S.A.; Nandi U.; Patki D.; Viele K.; Effect of levocarnitine vs placebo as an adjunctive treatment for septic shock: the Rapid Administration of Carnitine in Sepsis (RACE) randomized clinical trial. JAMA Netw Open 2018,1(8),e186076-e186076","journal-title":"JAMA Netw Open"},{"key":"ref=162","doi-asserted-by":"publisher","first-page":"A2604","DOI":"10.1164\/ajrccm-conference.2020.201.1_MeetingAbstracts.A2604","author":"Puskarich M.","year":"2020","unstructured":"Puskarich M.; Pretreatment Acetyl-Carnitine Levels Predict Mortality Benefit from L-Carnitine Treatment in Sepsis: A Pharmacometabolomics Based Clinical Trial Enrichment Strategy A103 SEPSIS: TRANSLATIONAL STUDIES 2020,A2604","journal-title":"A103 SEPSIS: TRANSLATIONAL STUDIES"},{"key":"ref=163","doi-asserted-by":"publisher","first-page":"2004","DOI":"10.1021\/acs.jproteome.8b00774","volume":"18","author":"Evans C.R.","year":"2019","unstructured":"Evans C.R.; Karnovsky A.; Puskarich M.A.; Michailidis G.; Jones A.E.; Stringer K.A.; Untargeted metabolomics differentiates L-carnitine treated Septic shock 1-year survivors and nonsurvivors. J Proteome Res 2019,18(5),2004-2011","journal-title":"J Proteome Res"},{"key":"ref=164","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1002\/phar.2448","volume":"40","author":"Jennaro T.S.","year":"2020","unstructured":"Jennaro T.S.; Puskarich M.A.; McCann M.R.; Gillies C.E.; Pai M.P.; Karnovsky A.; Evans C.R.; Jones A.E.; Stringer K.A.; Using l-carnitine as a pharmacologic probe of the interpatient and metabolic variability of sepsis. Pharmacotherapy 2020,40(9),913-923","journal-title":"Pharmacotherapy"},{"key":"ref=165","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1177\/014860718801200129","volume":"12","author":"Gibault J.P.","year":"1988","unstructured":"Gibault J.P.; Frey A.; Guiraud M.; Schirardin H.; Bouletreau P.; Bach A.C.; Effects of L-carnitine infusion on intralipid clearance and utilization. Study carried out in septic patients of an intensive care unit. JPEN J Parenter Enteral Nutr 1988,12(1),29-34","journal-title":"JPEN J Parenter Enteral Nutr"},{"key":"ref=166","first-page":"18","volume":"2","author":"Mohammadzadeh A.","year":"2011","unstructured":"Mohammadzadeh A.; Clinical effects of carnitin supplementation on hypoglycemia, apnea and sepsis in very low birth weight neonates. Iran J Neonatol 2011,2(1),18-21","journal-title":"Iran J Neonatol"},{"key":"ref=167","first-page":"627","volume":"34","author":"Li L.","year":"2018","unstructured":"Li L.; Wang F.; Effect of L-carnitine injection on platelet and mitochondria of patients with septic shock. J Pract Med 2018,34(4),627-629","journal-title":"J Pract Med"},{"key":"ref=168","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1177\/0897190018782012","volume":"33","author":"Hogan P.","year":"2020","unstructured":"Hogan P.; Plourde R.; Fortier M.; Brindamour D.; Lagrenade-Verdant C.; Demers-Marcil S.; Dupuis S.; Refractory hyperlactatemia after a septic shock in a patient with carnitine deficiency: a case report. J Pharm Pract 2020,33(1),113-116","journal-title":"J Pharm Pract"},{"key":"ref=169","first-page":"14","volume":"9","author":"Yahyapoor F.","year":"2021","unstructured":"Yahyapoor F.; L-Carnitine Effects on Clinical Status and Mortality Rate in Septic Patients: A Systematic Literature Review. J Nutri Fasting Health 2021,9(1),14-22","journal-title":"J Nutri Fasting Health"},{"key":"ref=170","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1016\/j.biocel.2012.05.021","volume":"44","author":"Hill M.A.","year":"2012","unstructured":"Hill M.A.; Meininger G.A.; Arteriolar vascular smooth muscle cells: mechanotransducers in a complex environment. Int J Biochem Cell Biol 2012,44(9),1505-1510","journal-title":"Int J Biochem Cell Biol"},{"key":"ref=171","doi-asserted-by":"publisher","first-page":"2690","DOI":"10.2337\/db06-1228","volume":"56","author":"Le Gouill E.","year":"2007","unstructured":"Le Gouill E.; Jimenez M.; Binnert C.; Jayet P.Y.; Thalmann S.; Nicod P.; Scherrer U.; Vollenweider P.; Endothelial nitric oxide synthase (eNOS) knockout mice have defective mitochondrial \u03b2-oxidation. Diabetes 2007,56(11),2690-2696","journal-title":"Diabetes"},{"key":"ref=172","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.17576\/jsm-2015-4410-09","volume":"44","author":"Palipoch S.","year":"2015","unstructured":"Palipoch S.; Koomhin P.; Oxidative stress-associated pathology: a review. Sains Malays 2015,44(10),1441-1451","journal-title":"Sains Malays"},{"key":"ref=173","doi-asserted-by":"publisher","first-page":"72","DOI":"10.3389\/fcell.2014.00072","volume":"2","author":"Chiong M.","year":"2014","unstructured":"Chiong M.; Cartes-Saavedra B.; Norambuena-Soto I.; Mondaca-Ruff D.; Morales P.E.; Garc\u00eda-Miguel M.; Mellado R.; Mitochondrial metabolism and the control of vascular smooth muscle cell proliferation. Front Cell Dev Biol 2014,2,72","journal-title":"Front Cell Dev Biol"},{"key":"ref=174","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1016\/S0891-5849(02)00961-9","volume":"33","author":"Salvemini D.","year":"2002","unstructured":"Salvemini D.; Cuzzocrea S.; Oxidative stress in septic shock and disseminated intravascular coagulation. Free Radic Biol Med 2002,33(9),1173-1185","journal-title":"Free Radic Biol Med"},{"key":"ref=175","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1111\/j.1542-4758.2010.00476.x","volume":"14","author":"Shakeri A.","year":"2010","unstructured":"Shakeri A.; Tabibi H.; Hedayati M.; Effects of L-carnitine supplement on serum inflammatory cytokines, C-reactive protein, lipoprotein (a), and oxidative stress in hemodialysis patients with Lp (a) hyperlipoproteinemia. Hemodial Int 2010,14(4),498-504","journal-title":"Hemodial Int"},{"key":"ref=176","doi-asserted-by":"publisher","first-page":"C392","DOI":"10.1152\/ajpcell.00125.2016","volume":"311","author":"Bilodeau P.A.","year":"2016","unstructured":"Bilodeau P.A.; Coyne E.S.; Wing S.S.; The ubiquitin proteasome system in atrophying skeletal muscle: roles and regulation. Am J Physiol Cell Physiol 2016,311(3),C392-C403","journal-title":"Am J Physiol Cell Physiol"},{"key":"ref=177","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1016\/j.molmed.2019.05.008","volume":"25","author":"Hnia K.","year":"2019","unstructured":"Hnia K.; Clausen T.; Moog-Lutz C.; Shaping striated muscles with ubiquitin proteasome system in health and disease. Trends Mol Med 2019,25(9),760-774","journal-title":"Trends Mol Med"},{"key":"ref=178","doi-asserted-by":"publisher","first-page":"5358","DOI":"10.3390\/ijms21155358","volume":"21","author":"Yamazaki O.","year":"2020","unstructured":"Yamazaki O.; Hirohama D.; Ishizawa K.; Shibata S.; Role of the ubiquitin proteasome system in the regulation of blood pressure: a review. Int J Mol Sci 2020,21(15),5358","journal-title":"Int J Mol Sci"},{"key":"ref=179","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1017\/S1751731111001327","volume":"6","author":"Keller J.","year":"2012","unstructured":"Keller J.; Ringseis R.; Koc A.; Lukas I.; Kluge H.; Eder K.; Supplementation with l-carnitine downregulates genes of the ubiquitin proteasome system in the skeletal muscle and liver of piglets. Animal 2012,6(1),70-78","journal-title":"Animal"},{"key":"ref=180","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.3892\/mmr.2013.1378","volume":"7","author":"Nagano K.","year":"2013","unstructured":"Nagano K.; Ishida J.; Unno M.; Matsukura T.; Fukamizu A.; Apelin elevates blood pressure in ICR mice with L-NAME-induced endothelial dysfunction. Mol Med Rep 2013,7(5),1371-1375","journal-title":"Mol Med Rep"},{"key":"ref=181","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.pharmthera.2018.05.013","volume":"190","author":"Mughal A.","year":"2018","unstructured":"Mughal A.; O\u2019Rourke S.T.; Vascular effects of apelin: Mechanisms and therapeutic potential. Pharmacol Ther 2018,190,139-147","journal-title":"Pharmacol Ther"},{"key":"ref=182","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1093\/jb\/mvaa129","volume":"169","author":"Rikitake Y.","year":"2021","unstructured":"Rikitake Y.; The apelin\/APJ system in the regulation of vascular tone: Friend or foe? J Biochem 2021,169(4),383-386","journal-title":"J Biochem"},{"key":"ref=183","doi-asserted-by":"publisher","first-page":"e14641","DOI":"10.14814\/phy2.14641","volume":"8","author":"Ranjbar Kohan N.","year":"2020","unstructured":"Ranjbar Kohan N.; Tabandeh M.R.; Nazifi S.; Soleimani Z.; L-carnitine improves metabolic disorders and regulates apelin and apelin receptor genes expression in adipose tissue in diabetic rats. Physiol Rep 2020,8(23),e14641","journal-title":"Physiol Rep"},{"key":"ref=184","first-page":"427","volume":"20","author":"Ranjbar Kohan N.","year":"2018","unstructured":"Ranjbar Kohan N.; Nazifi S.; Tabandeh M.R.; Ansari Lari M.; Effect of l-carnitine supplementation on apelin and apelin receptor (Apj) expression in cardiac muscle of obese diabetic rats. Cell J 2018,20(3),427-434","journal-title":"Cell J"},{"key":"ref=185","first-page":"38","volume":"21","author":"Abdul-Razzaka F.S.","year":"2019","unstructured":"Abdul-Razzaka F.S.; Mohammed M.J.; Mustafaa E.M.; Synergistic effect of l-carnitine, omega-3 with metformin on the level of apelin-36 and some hormones in rabbits induced with diabetes. Asian J Microbiol Biotech 2019,21(1),38-45","journal-title":"Asian J Microbiol Biotech"},{"key":"ref=186","author":"Council N.R.","year":"1989","unstructured":"Council N.R.;  Recommended dietary allowances 1989","journal-title":"Recommended dietary allowances"},{"key":"ref=187","doi-asserted-by":"publisher","first-page":"ix","DOI":"10.1196\/annals.1320.019","volume":"1033","author":"Alesci S.","year":"2004","unstructured":"Alesci S.; Carnitine: Lessons from one hundred years of research. Ann N Y Acad Sci 2004,1033,ix-xi","journal-title":"Ann N Y Acad Sci"},{"key":"ref=188","year":"2000","unstructured":"Institute of Medicine (US) Subcommittee on Interpretation and Uses of Dietary Reference Intakes; Institute of Medicine (US) Standing Committee on the Scientific Evaluation of Dietary Reference Intakes. DRI Dietary Reference Intakes: Applications in dietary assessment. 2000"},{"key":"ref=189","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.yrtph.2006.06.007","volume":"46","author":"Hathcock J.N.","year":"2006","unstructured":"Hathcock J.N.; Shao A.; Risk assessment for carnitine. Regul Toxicol Pharmacol 2006,46(1),23-28","journal-title":"Regul Toxicol Pharmacol"},{"key":"ref=190","author":"Maurice E.S.","year":"2019","unstructured":"Maurice E.S.;  Modern Nutrition in Health and Disease 2019","journal-title":"Modern Nutrition in Health and Disease"},{"key":"ref=191","author":"Cho S.","year":"2003","unstructured":"Cho S.; Park Y.; Cha Y.; Plasma and urinary carnitine concentrations in pregnant Korean women. FASEB J 2003","journal-title":"FASEB J"},{"key":"ref=192","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1038\/ejcn.2009.36","volume":"63","author":"Keller U.","year":"2009","unstructured":"Keller U.; van der Wal C.; Seliger G.; Scheler C.; R\u00f6pke F.; Eder K.; Carnitine status of pregnant women: effect of carnitine supplementation and correlation between iron status and plasma carnitine concentration. Eur J Clin Nutr 2009,63(9),1098-1105","journal-title":"Eur J Clin Nutr"},{"key":"ref=193","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1016\/j.jpainsymman.2006.09.001","volume":"32","author":"Cruciani R.A.","year":"2006","unstructured":"Cruciani R.A.; Dvorkin E.; Homel P.; Malamud S.; Culliney B.; Lapin J.; Portenoy R.K.; Esteban-Cruciani N.; Safety, tolerability and symptom outcomes associated with L-carnitine supplementation in patients with cancer, fatigue, and carnitine deficiency: a phase I\/II study. J Pain Symptom Manage 2006,32(6),551-559","journal-title":"J Pain Symptom Manage"},{"key":"ref=194","first-page":"486","volume":"15","author":"Rubin M.R.","year":"2001","unstructured":"Rubin M.R.; Volek J.S.; G\u00f3mez A.L.; Ratamess N.A.; French D.N.; Sharman M.J.; Kraemer W.J.; Safety measures of L-carnitine L-tartrate supplementation in healthy men. J Strength Cond Res 2001,15(4),486-490","journal-title":"J Strength Cond Res"},{"key":"ref=195","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1053\/j.jrn.2018.08.014","volume":"29","author":"Davani-Davari D.","year":"2019","unstructured":"Davani-Davari D.; Karimzadeh I.; Sagheb M.M.; Khalili H.; The renal safety of L-carnitine, L-arginine, and glutamine in athletes and bodybuilders. J Ren Nutr 2019,29(3),221-234","journal-title":"J Ren Nutr"},{"key":"ref=196","doi-asserted-by":"publisher","first-page":"162","DOI":"10.4103\/0972-5229.117054","volume":"17","author":"Sundar K.M.","year":"2013","unstructured":"Sundar K.M.; Sires M.; Sepsis induced immunosuppression: Implications for secondary infections and complications. Indian J Crit Care Med 2013,17(3),162-169","journal-title":"Indian J Crit Care Med"},{"key":"ref=197","doi-asserted-by":"publisher","first-page":"R153","DOI":"10.1186\/cc2858","volume":"8","author":"van Gestel A.","year":"2004","unstructured":"van Gestel A.; Bakker J.; Veraart C.P.; van Hout B.A.; Prevalence and incidence of severe sepsis in Dutch intensive care units. Crit Care 2004,8(4),R153-R162","journal-title":"Crit Care"}],"container-title":["Current Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0929867328666211117092345","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/197971\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0929867328666211117092345","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,19]],"date-time":"2022-07-19T22:03:48Z","timestamp":1658268228000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/197971\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":197,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0929867328666211117092345","relation":{},"ISSN":["0929-8673"],"issn-type":[{"value":"0929-8673","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2021-04-13","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-08-19","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-08-21","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-05-16","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}